Protalix BioTherapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2024
Total Assets: $73.4M
Liabilities Breakdown FY2024
Total Liabilities: $30.2M
Asset Breakdown
Total Assets: $73.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $19.8M | 26.9% |
| Accounts Receivable | $2.9M | 4.0% |
| Inventory | $21.2M | 28.9% |
| Property, Plant & Equipment | $4.6M | 6.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $24.9M | 33.9% |
Liabilities Breakdown
Total Liabilities: $30.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.5M | 15.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $25.7M | 85.0% |